Find Docs

BioTech Navigator Investment Newsletter - News 8 97 (Page 8)

Wodocs >> Business : Biotechnology and Pharmaceuticals >> BioTech Navigator Investment Newsletter News 8 97 Page 8
BioTech Navigator Investment Newsletter - News 8 97
8
BioTech Navigator, August 1997
52 Week Trading History
Amgen develops, manufac-
tures and markets human therapeutics
based on advanced cellular and
molecular biology. Therapeutic prod-
ucts manufactured include Neupogen,
stimulates white blood cells and
Epogen, stimulates red blood cells.
Amgen focuses its research on biolog-
ical cell/tissue events and its develop-
ment efforts on human therapeutics in
the areas of hematopoiesis, neurobiol-
ogy, endocrinology, inflammation and
soft tissue repair and regeneration.
Despite a dip in sales growth
of its leading drug, Amgen, posted a
12% increase in second-quarter net
income to $200.5 million, or 72 cents
a share. In the year-earlier period,
Amgen had net income of $178.7 mil-
lion, or 64 cents a share. Second-
quarter revenue rose 9% to $620.5
million. Sales of Amgen's top-selling
anemia drug, Epogen, rose 12% in the
latest quarter to $295 million. Amgen
warned last month that it expected a
Sales of Neupogen, which is
used to boost white blood cell counts
in cancer and AIDS patients, rose 7%
to $272 million from $255 million in
second quarter 1996. Amgen officials
said the use of protease inhibitors has
affected Neupogen usage by AIDS
patients, but that appears to be offset
by sales growth among cancer pa-
tients.
A FDA panel recommended
Amgen's Neupogen as being safe and
effective as an adjunct to chemother-
apy for treating acute myeloid
leukemia.
An estimated 10,000 Ameri-
cans suffer from acute myeloid
leukemia.
Several members of the
FDA's Biolgical Response Modifiers
Advisory Committee commended the
company for doing the studies in at-
tempt to gain an additional indication.
Supposedly the drug is already used
off-label by many doctors for the pro-
posed indication. If it is ultimately
approved by the FDA, the additional
indication would allow patients to get
reimbursement from their insurance
providers.
Amgen Inc.
Overview
Status
"modest reduction" in the growth rate
of Epogen. Epogen sales were hurt by
actions taken by dialysis providers in
response to the changes in Medicare
reimbursement regulations which will
become effective Sept. 1
st
. Amgen
expects Epogen sales growth in the
second half to be about the same as
the 15% growth rate in the first half.
That would be a significant slowdown
from last year, when Epogen sales
increased 21%.
Product Pipeline (Abbreviated)
Product
Indication
Status
Epogen
Nephrology
Marketed
Neupogen
Oncology/Infectious disease
Marketed to Phase lll
Infergen
Hempatology
Filed for Approval
Stemgen, MGDF, KGF,
Cell Selection Device
Oncology
Phase lll to Phase l/ll
NT-3, BDNF, GDNF,
Leptin
Neurology/Endocrinology
Phase l/ll
IL-Ira, TNF-bp, R-568
Inflammation
Phase l/ll, Preclinical
NESP
Nephrology
Phase l/ll

<< Previous       1 2 3 4 5 6 7 8 9 10 11 12 13 14 15       Next >>



Other Documents:
01 01 News Color, 1 00 News, 1 04 News Color Blank, Handpainted Catalog F, Oil Lamps Unlimited E Brochure, Order Form Retailb, Order Form specialpricing, jobapplication, SFmenu 2006, jobapplication, reheating, Holiday menu 2005 2, Signe's Holiday Menu, Holiday menu 2005 2, 22 aug 2001, 22 sept 2003, 31 Aug 2002, Eagles 121605, Rose Bowl Fan 2 Fan 120505, Rose Bowl Preferred 111405, C 15 Entry Form pg 2 ( ENG), C 15 Entry Form pg 2 ( FR), C17 entryform, C18 Community serv, Contessa 15 Finalists, Contessa 15 Semi Finalists, contessa 14 finalists, c16 eng entryform, c16 fr entryform, b.loreal.comp, checklist, Beautynet ad info, CIABC MK, Elevate Media Kit, Salon Ad Specs, hair removal options, Amst Menu Guide 07 02, Amst Menu Guide 07 04, Amst Menu Guide 07 05, Amst Menu Guide 07 06, Amst Menu Guide 07 07, Amst Menu Guide 07 08, Amst Menu Guide 07 09, Amst Menu Guide 07 10, Amst Menu Guide 07 11, Amst Menu Guide 07 13, Amst Menu Guide 07 14, Amst Menu Guide 07 19, Amst Menu Guide 07 24, Amst Menu Guide 07 25,


WODocs | |
All rights reserved. wodocs.com© 2009
WODocs


New Docs

Documents Category:
Arts (Design, Movies, Music, Radio, Television)
Automotive (Cars, Marine, Motorcycle, ATV, Snowmobiles)
Business (Biotechnology and Pharmaceuticals, Chemicals, Construction and Maintenance, Materials, Real Estate, Services)
Electronics (Computers, Motion Control, Power Supply)
Games (Board, Family, Party, Card, Construction, RC Toys)
Health (Animalm, Beauty, Healthcare, Medicine, Pharmacy, Surgery, Weight Loss)
Home (Accessories, Cooking, Decor and Design, Electrical, Family, Pets)
News (Newspapers, Sports, Television)
Recreation (Collecting, Hiking, Scouting, Survival, Travel)
Reference (Education, Libraries and Archives, Museums)
Science (Agriculture, Astronomy, Biology, Chemistry)
Shopping (Antiques and Collectibles, Clothing, Flowers, Food, Home and Garden)
Sports (Bicycle, Snowboard, Skiing, Other)